Short-Term Methylcobalamin Supplementation Is Associated with Changes in Anaerobic and Cognitive Performance in Amateur Cyclists: A Randomized Crossover Trial
Nutraceuticals · 23.05.2026 · 6 (2) · 35
DOI: 10.3390/nutraceuticals6020035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutraceuticals, online erschienen am 23.05.2026. Verfasst von Francisco Javier Martínez-Noguera und 4 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HealthTech BioActives S.L.U..
Abstract (Originalsprache)
Introduction
Vitamin B12 (VB12), particularly its active form methylcobalamin (MeB12), contributes to neuromuscular function and energy metabolism, which may be relevant for sports performance. However, evidence on the acute effects of MeB12 supplementation in athletes remains limited.
Objective
To evaluate the effects of short-term (3-day) MeB12 supplementation on anaerobic and cognitive performance in amateur cyclists.
Methods
A randomized, triple-blind, placebo-controlled crossover clinical trial was conducted in 18 amateur cyclists. Participants received formulations containing MeB12 (1 mg/day; MecobalActive®, HTBA, Murcia, Spain) or placebo for three consecutive days. Anaerobic performance was assessed using a repeated Wingate protocol, and cognitive performance was evaluated using a light-based mental agility/reaction test system. Biochemical analyses included serum VB12 concentrations. Primary outcomes included peak power output (absolute and relative), fatigue index across repeated sprints, and cognitive response time.
Results
Compared with placebo, MeB12 supplementation was associated with higher peak power output, with increases in absolute maximal power (PMAX: +4.1%, p = 0.016) and relative maximal power (PMAXREL: +4.4%, p = 0.013). MeB12 supplementation was associated with a smaller decline in performance across repeated sprints, with a smaller drop in fatigue index from the first to the fifth sprint (p = 0.012). Pre-exercise cognitive performance improved, with a shorter total reaction test time (−4.9%, p < 0.001) versus placebo. Serum VB12 concentrations increased by 16.8% following MeB12 supplementation.
Conclusions
A brief, 3-day intervention with methylcobalamin (1 mg/day) was associated with positive changes, when compared with placebo, in selected markers of anaerobic performance (peak power and fatigue-related decline) and pre-exercise cognitive performance in recreationally trained amateur cyclists, suggesting a possible involvement of peripheral and central mechanisms.
Förderung
- HealthTech BioActives S.L.U.
Zitieren
APA
Martínez-Noguera, F. J., Alcaraz, P. E., Blanc, F. J. G., Huyghe, T. G., & Marín-Pagán, C. (2026). Short-Term Methylcobalamin Supplementation Is Associated with Changes in Anaerobic and Cognitive Performance in Amateur Cyclists: A Randomized Crossover Trial. Nutraceuticals, 6(2), 35. https://doi.org/10.3390/nutraceuticals6020035
Vancouver
Martínez-Noguera FJ, Alcaraz PE, Blanc FJG, Huyghe TG, Marín-Pagán C. Short-Term Methylcobalamin Supplementation Is Associated with Changes in Anaerobic and Cognitive Performance in Amateur Cyclists: A Randomized Crossover Trial. Nutraceuticals. 2026;6(2):35. doi:10.3390/nutraceuticals6020035
BibTeX
@article{MartnezNoguera2026,
author = {Martínez-Noguera, Francisco Javier and Alcaraz, Pedro E. and Blanc, Francisco Jesús González and Huyghe, Thomas G. and Marín-Pagán, Cristian},
title = {Short-Term Methylcobalamin Supplementation Is Associated with Changes in Anaerobic and Cognitive Performance in Amateur Cyclists: A Randomized Crossover Trial},
journal = {Nutraceuticals},
year = {2026},
volume = {6},
number = {2},
pages = {35},
doi = {10.3390/nutraceuticals6020035}
}
EUVIMED